2014
A phase II trial of balloon-catheter partial breast brachytherapy optimization in the treatment of stage 0, I, and IIA breast carcinoma
Nath SK, Chen ZJ, Rowe BP, Blitzblau RC, Aneja S, Grube BJ, Horowitz NR, Weidhaas JB. A phase II trial of balloon-catheter partial breast brachytherapy optimization in the treatment of stage 0, I, and IIA breast carcinoma. Journal Of Radiation Oncology 2014, 3: 371-378. PMID: 25485042, PMCID: PMC4254816, DOI: 10.1007/s13566-014-0153-8.Peer-Reviewed Original ResearchSuperior PTV coverageSkin toxicityPTV coverageStage 0Single-arm phase II studyAcute grade 2 toxicityGrade 2 skin toxicityCommon acute toxicitiesGrade 1 erythemaGrade 1 fibrosisGrade 2 toxicityPhase II studyPhase II trialPartial breast irradiationBalloon catheter brachytherapyLower skin dosesOverall low rateMedian V90II trialPrimary endpointII studyAdditional patientsTreatment eligibilityBreast irradiationBrachytherapy results
2011
A novel modified dynamic conformal arc technique for treatment of peripheral lung tumors using stereotactic body radiation therapy
Ross CC, Kim JJ, Chen ZJ, Grew DJ, Chang BW, Decker RH. A novel modified dynamic conformal arc technique for treatment of peripheral lung tumors using stereotactic body radiation therapy. Practical Radiation Oncology 2011, 1: 126-134. PMID: 24673926, DOI: 10.1016/j.prro.2010.11.002.Peer-Reviewed Original ResearchNormal tissue dose constraintsStereotactic body radiation therapyBody radiation therapyDynamic conformal arc techniqueRadiation therapyDose constraintsNon-small cell lung cancerLung stereotactic body radiation therapyChest wall doseMedian lung V20RTOG 0236 protocolPeripheral lung tumorsCell lung cancerNormal tissue constraintsLower maximum doseTreatment volume coverageRTOG protocolInoperable patientsConsecutive patientsLung V20Lung doseLung cancerPTV coverageLung tumorsSeparate cohort